---
title: "UnitedHealth dips 1% as Zacks cuts Q3 EPS estimate to $4.74"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296511995.md"
description: "UnitedHealth fell nearly 1% after Zacks Research lowered its Q3 FY2027 EPS estimate to $4.74."
datetime: "2026-08-20T15:21:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296511995.md)
  - [en](https://longbridge.com/en/news/296511995.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296511995.md)
generator: "portal-rs"
---

# UnitedHealth dips 1% as Zacks cuts Q3 EPS estimate to $4.74

联合健康 (UNH.US) 盘中跌近 1%，现报**386.3**美元。

消息面方面，Zacks Research 将联合健康 2027 财年第三季度每股收益预估从 4.81 美元下调至**4.74**美元，维持

### Related Stocks

- [UNH.US](https://longbridge.com/en/quote/UNH.US.md)

## Related News & Research

- [UnitedHealth Is Trouncing the Market in 2026. Is the Stock Still a Buy?](https://longbridge.com/en/news/298009355.md)
- [UnitedHealth Group (UNH), Why Is The Market Paying Closer Attention Now?](https://longbridge.com/en/news/297410284.md)
- [Washington Trust Bank Has $12.27 Million Position in UnitedHealth Group Incorporated $UNH](https://longbridge.com/en/news/297422601.md)
- [B. Metzler seel. Sohn & Co. AG Grows Stock Position in Regeneron Pharmaceuticals, Inc. $REGN](https://longbridge.com/en/news/298098855.md)
- [Novartis announces Phase 3 pelacarsen study did not meet primary endpoint](https://longbridge.com/en/news/298086918.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**